Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Stock Picks For Healthy Returns
Nov 25, 2008 10:19 AM
- Celgene: Blockbuster Biotech Bet
Nov 10, 2008 10:23 AM
- Earnings Gap Trade - Amgen, Inc.
Oct 23, 2008 11:07 PM
- Analyst Comments: Joy Global, Photronics, Martha Stewart, Kellogg, Red Robin, Cirrus Logic, Safeway, PACCAR, Celgene, AstraZeneca, Phase Forward, Digital River, Methanex, Grupo Televisa, HSBC, AAR Corp, Centennial, Carmike Cinema, Washington Post
Oct 10, 2008 10:10 AM
- Biotechs: Buy The Big Dip Phase?
Sep 29, 2008 12:34 PM
- FDA Slow to Approve Drugs, For Now
Sep 05, 2008 10:15 AM
- The Wagner Daily - August 29, 2008
Aug 29, 2008 08:09 AM
- Periodicals Wrap-Up for Thursday, August 21
Aug 21, 2008 09:51 AM
- Institutional Money Flocking in Biotech
Aug 15, 2008 01:23 PM
- Periodicals Wrap-Up for Tuesday, August 12th
Aug 12, 2008 10:41 AM
- Celgene Corporation to Present at the Lazard Capital Markets
5th Annual Healthcare Conference
Nov 17, 2008 04:31 PM
- US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
Nov 12, 2008 08:03 AM
- Celgene Cellular Therapeutics Receives FDA Clearance for First Placenta-Derived Stem Cell Clinical Study
Nov 10, 2008 07:32 AM
- Celgene Corporation to Present at the 2008 Credit Suisse Annual Health Care Conference
Nov 07, 2008 07:32 AM
- Celgene Corporation to Present at the Rodman & Renshaw Annual Global Investment Conference
Nov 06, 2008 04:44 PM
- Market Pulse Announces Its Hot Stock Alerts for Thursday, November 6, 2008: PRRY, CELG, CEGE, AMZN
Nov 06, 2008 10:23 AM
- Celgene Corporation to Present at the Oppenheimer 19th Annual Healthcare Conference
Oct 31, 2008 04:31 PM
- Seven Summits Research Releases Alerts on HIG, PG, APA, CELG, and SPLS
Oct 31, 2008 09:43 AM
- Cancer Drug Vidaza(R) Receives Positive Opinion from European Regulatory Authority for Treatment of MDS and AML
Oct 24, 2008 05:36 AM
- Celgene Reports Record Third Quarter 2008 Product Sales and Operating Profits
Oct 23, 2008 07:32 AM
- Form 4 CELGENE CORP /DE/ For: Nov 07 Filed by: ROBB WALTER L (10K)
Nov 07, 2008 01:03 PM
- Form 4 CELGENE CORP /DE/ For: Nov 03 Filed by: GRYSKA DAVID W (10K)
Nov 05, 2008 06:18 PM
- Form 4 CELGENE CORP /DE/ For: Nov 03 Filed by: Burton Graham (10K)
Nov 05, 2008 06:17 PM
- Form 4 CELGENE CORP /DE/ For: Nov 03 Filed by: Van Hoek Andre (10K)
Nov 05, 2008 06:14 PM
- Form 4 CELGENE CORP /DE/ For: Nov 03 Filed by: HUGIN ROBERT J (10K)
Nov 05, 2008 06:14 PM
- Form 4 CELGENE CORP /DE/ For: Oct 14 Filed by: Burton Graham (10K)
Oct 15, 2008 06:36 PM
- Form 4 CELGENE CORP /DE/ For: Oct 14 Filed by: GRYSKA DAVID W (10K)
Oct 15, 2008 06:35 PM
- Form 4 CELGENE CORP /DE/ For: Oct 14 Filed by: BROUWER AART (10K)
Oct 15, 2008 06:32 PM
- Form 4 CELGENE CORP /DE/ For: Oct 14 Filed by: HUGIN ROBERT J (10K)
Oct 15, 2008 06:29 PM
- Form 4 CELGENE CORP /DE/ For: Oct 14 Filed by: Van Hoek Andre (10K)
Oct 15, 2008 06:27 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
CELG
|
Compare to S&P
|
| YTD |
12.75 %
|
84.72 %
|
| 4 Weeks |
-18.92 %
|
-12.36 %
|
| 12 Weeks |
-21.31 %
|
9.07 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 9.68 %
|
|
EPS Growth in Last Year: 17.24 %
|
|
Sales Growth in Last Quarter: 3.67 %
|
|
Sales Growth in Last Quarter: 69.32 %
|
|
|
